EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 73 filers reported holding EDGEWISE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,536,875 | -26.1% | 3,933,137 | 0.0% | 0.50% | -23.7% |
| Q2 2023 | $30,481,812 | +16.2% | 3,933,137 | 0.0% | 0.65% | +11.3% |
| Q1 2023 | $26,234,024 | -25.4% | 3,933,137 | 0.0% | 0.58% | -19.6% |
| Q4 2022 | $35,162,245 | -9.1% | 3,933,137 | 0.0% | 0.73% | -5.5% |
| Q3 2022 | $38,702,000 | +23.6% | 3,933,137 | 0.0% | 0.77% | +19.2% |
| Q2 2022 | $31,308,000 | -17.9% | 3,933,137 | 0.0% | 0.65% | -24.3% |
| Q1 2022 | $38,151,000 | -36.5% | 3,933,137 | 0.0% | 0.85% | -32.4% |
| Q4 2021 | $60,098,000 | -8.0% | 3,933,137 | 0.0% | 1.26% | -1.0% |
| Q3 2021 | $65,290,000 | -22.2% | 3,933,137 | 0.0% | 1.27% | -14.5% |
| Q2 2021 | $83,894,000 | -34.4% | 3,933,137 | 0.0% | 1.49% | -44.5% |
| Q1 2021 | $127,827,000 | – | 3,933,137 | – | 2.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $8,902,478 | 11.43% |
| Novo Holdings A/S | 6,071,703 | $34,790,858 | 2.57% |
| Orbimed Advisors | 14,567,176 | $83,469,918 | 1.77% |
| Opaleye Management Inc. | 875,405 | $5,016,071 | 1.63% |
| Cormorant Asset Management, LP | 2,946,887 | $16,885,663 | 0.98% |
| DAFNA Capital Management LLC | 519,384 | $2,976,070 | 0.93% |
| EcoR1 Capital, LLC | 3,493,194 | $20,016,002 | 0.68% |
| Deep Track Capital, LP | 2,750,000 | $15,757,500 | 0.61% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $22,536,875 | 0.50% |
| Parkman Healthcare Partners LLC | 473,312 | $2,712,078 | 0.50% |